This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.
Stocks · News reference
8-K filing — Pediatrix Medical Group, Inc. (MD)
Filed: 2026-08-04 AccNo: 0001193125-26-331488 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call
Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to